{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:25:43Z","timestamp":1772166343296,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"This work was supported by the National Natural Science Foundation of China","award":["81601660"],"award-info":[{"award-number":["81601660"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Scand J Trauma Resusc Emerg Med"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>MiRNA-155 and miRNA-145 have been demonstrated to function as a key regulator in the development of the cardiovascular system. Recent experimental and clinical studies have indicated the cardioprotective role of sildenafil during ischemia\/reperfusion (I\/R) injury. This study was designed to investigate if administration of sildenafil will attenuate post-resuscitation myocardial dysfunction by regulating miRNA-155 and miR-145 expressions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Thirty-two male pigs (weighing 30\u2009\u00b1\u20092\u2009kg) were randomly divided into 4 groups, sildenafil group (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20098), sildenafil +NG-nitro-l-arginine methyl ester (L-NAME) (20\u2009mg\/kg\u2009L) group (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20098), saline (SA group,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20098); and sham operation group (sham group,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20098). Eight minutes of untreated VF was followed by defibrillation in anesthetized, closed-chest pigs. Hemodynamic status and blood samples were obtained at 0\u2009min, 0.5, 1, 2, 4 and 6\u2009h after return of spontaneous circulation (ROSC), and the hearts were removed and analyzed under electron microscopy, quantitative real-time polymerase chain reaction and ultra structural analysis were performed to evaluate myocardial injury.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Compared with the sildenafil + L-NAME and saline groups, the sildenafil group had better outcomes in terms of hemodynamic and oxygen metabolism parameters as well as 24-h survival rate, and attenuated myocardial injury; In this study, CA pigs showed evidently increased levels of miR-155-5p and miR-145-5p, while the sildenafil treatment decreased the levels of miR-155-5p and miR-145-5p in CA pigs. In addition, the levels of eNOS was decreased in CA pigs, validating sildenafil attenuating post-resuscitation myocardial dysfunction by regulating miRNA-155 and miR-145 expressions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Sildenafil group had better outcomes in terms of hemodynamic and oxygen metabolism parameters as well as 24-h survival rate, inhibited the increases in the miR-155-5p and miR-145-5p levels and attenuated myocardial injury in a porcine model of CA and resuscitation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13049-020-00819-5","type":"journal-article","created":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T11:08:06Z","timestamp":1609931286000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The protective effects of phosphodiesterase-5 inhibitor, sildenafil on post-resuscitation cardiac dysfunction of cardiac arrest: by regulating the miR-155-5p and miR-145-5p"],"prefix":"10.1186","volume":"29","author":[{"given":"Yong","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoxing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2251-6190","authenticated-orcid":false,"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,6]]},"reference":[{"issue":"10124","key":"819_CR1","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/S0140-6736(18)30315-5","volume":"391","author":"C Hassager","year":"2018","unstructured":"Hassager C, Nagao K, Hildick-Smith D. Out-of-hospital cardiac arrest: inhospital intervention strategies. Lancet. 2018;391(10124):989\u201398.","journal-title":"Lancet"},{"key":"819_CR2","doi-asserted-by":"publisher","first-page":"A12","DOI":"10.1016\/j.resuscitation.2017.10.013","volume":"121","author":"SD Mentzelopoulos","year":"2017","unstructured":"Mentzelopoulos SD, Zakynthinos SG. Post-cardiac\u2002arrest\u2002syndrome: pathological processes, biomarkers and vasopressor support, and potential therapeutic targets. Resuscitation. 2017;121:A12\u20134.","journal-title":"Resuscitation."},{"issue":"3","key":"819_CR3","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/MCC.0b013e3283607740","volume":"19","author":"W Bougouin","year":"2013","unstructured":"Bougouin W, Cariou A. Management of postcardiac arrest\u2002myocardial\u2002dysfunction. Curr Opin Crit Care. 2013;19(3):195\u2013201.","journal-title":"Curr Opin Crit Care"},{"key":"819_CR4","first-page":"6969053","volume":"2020","author":"M Yang","year":"2020","unstructured":"Yang M, Hua T, Yang Z, Chen L, Zou Y, Huang X, Li J. The protective effect of rhBNP on\u2002Postresuscitation\u2002MyocardialDysfunction\u2002in a rat cardiac arrest model. Biomed Res Int. 2020;2020:6969053.","journal-title":"Biomed Res Int"},{"issue":"1","key":"819_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1055\/s-0034-1397344","volume":"35","author":"AM Mohr","year":"2015","unstructured":"Mohr AM, Mott JL. Overview of\u2002microRNA\u2002biology. Semin Liver Dis. 2015;35(1):3\u201311.","journal-title":"Semin Liver Dis"},{"issue":"1","key":"819_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1042\/BST20170037","volume":"46","author":"D Mellis","year":"2018","unstructured":"Mellis D, Caporali A. MicroRNA-based therapeutics in cardiovascular disease: screening and delivery to the target. Biochem Soc Trans. 2018;46(1):11\u201321.","journal-title":"Biochem Soc Trans"},{"issue":"9","key":"819_CR7","first-page":"1050","volume":"22","author":"JG Chen","year":"2019","unstructured":"Chen JG, Xu XM, Ji H, Sun B. Inhibiting miR-155 protects against myocardial ischemia\/reperfusion injury via targeted regulation of HIF-1\u03b1 in rats. Iran J Basic Med Sci. 2019;22(9):1050\u20138.","journal-title":"Iran J Basic Med Sci"},{"issue":"11","key":"819_CR8","first-page":"3677","volume":"10","author":"S Hu","year":"2018","unstructured":"Hu S, Cao S, Tong Z, Liu J. FGF21 protects myocardial ischemia-reperfusion injury through reduction of\u2002miR-145-mediated autophagy. Am J Transl Res. 2018;10(11):3677\u201388.","journal-title":"Am J Transl Res"},{"key":"819_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1476-5381.1991.tb12378.x","volume":"104","author":"R Schulz","year":"1991","unstructured":"Schulz R, Smith JA, Lewis MJ, Moncada S. Nitric oxide synthase in cultured endocardial cells of the pig. Br J Pharmacol. 1991;104:21\u20134.","journal-title":"Br J Pharmacol"},{"key":"819_CR10","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1006\/jmcc.2001.1462","volume":"33","author":"R Bolli","year":"2001","unstructured":"Bolli R. Cardio-protective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research. J Mol Cell Cardiol. 2001;33:1897\u2013918.","journal-title":"J Mol Cell Cardiol"},{"key":"819_CR11","doi-asserted-by":"crossref","unstructured":"Xu X, Tian L, Zhang Z.J. Triptolide inhibits angiogenesis in microvascular endothelial cells through regulation of miR-92a. Physiol Biochem 2019;75(4):573\u2013583.","DOI":"10.1007\/s13105-019-00707-2"},{"key":"819_CR12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12967-015-0550-9","volume":"13","author":"Q Zhang","year":"2015","unstructured":"Zhang Q, Wang G, Yuan W, Wu J, Wang M, Li C. The effects of phosphodiesterase-5 inhibitor sildenafil against post-resuscitation myocardial and intestinal microcirculatory dysfunction by attenuating apoptosis and regulating microRNAs expression: essential role of nitric oxide syntheses signaling. J Transl Med. 2015;13:177.","journal-title":"J Transl Med"},{"issue":"6","key":"819_CR13","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1186\/s13054-014-0641-7","volume":"18","author":"Q Zhang","year":"2014","unstructured":"Zhang Q, Yuan W, Wang G, Wu J, Wang M, Li CS. The protective effects of a phosphodiesterase 5 inhibitor, sildenafil, on postresuscitation cardiac dysfunction of cardiac arrest: metabolic evidence from microdialysis. Crit Care. 2014;18(6):641.","journal-title":"Crit Care"},{"key":"819_CR14","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical Association","year":"2013","unstructured":"World Medical Association. World medical association declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310:2191\u20134.","journal-title":"JAMA."},{"key":"819_CR15","doi-asserted-by":"publisher","first-page":"5194","DOI":"10.1021\/jf904536v","volume":"58","author":"Q Huang","year":"2010","unstructured":"Huang Q, Xu H, Yu Z, Gao P, Liu S. Inbred Chinese Wuzhishan (WZS) minipig model for soybean glycinin and \u03b2-conglycinin allergy. J Agric Food Chem. 2010;58:5194\u20138.","journal-title":"J Agric Food Chem"},{"issue":"3","key":"819_CR16","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1211\/jpp.62.03.0009","volume":"62","author":"TM Kolettis","year":"2010","unstructured":"Kolettis TM, Kontaras K, Spartinos I, Maniotis C, Varnavas V, Koutouzis M, Mourouzis I, Papalois A, Pantos C, Kyriakides ZS. Dose-dependent effects of sildenafil on post-ischaemic left ventricular function in the rat isolated heart. J Pharm Pharmacol. 2010;62(3):346\u201351.","journal-title":"J Pharm Pharmacol"},{"key":"819_CR17","doi-asserted-by":"publisher","first-page":"F362","DOI":"10.1152\/ajprenal.90609.2008","volume":"297","author":"DE Choi","year":"2009","unstructured":"Choi DE, Jeong JY, L Im BJ, Chung S, Chang YK, Lee SJ. Pretreatment of sildenafil attenuates ischemia-reperfusion renal injury in rats. Am J Physiol Renal Physiol. 2009;297:F362\u201370.","journal-title":"Am J Physiol Renal Physiol"},{"key":"819_CR18","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1161\/hc4501.098926","volume":"104","author":"RA Berg","year":"2001","unstructured":"Berg RA, Sanders AB, Kern KB, Hilwig RW, Heidenreich JW, Porter ME, Ewy GA. Adverse hemodynamic effects of interrupting chest compressions for rescue breathing during cardiopulmonary resuscitation for ventricular fibrillation cardiac arrest. Circulation. 2001;104:2465\u201370.","journal-title":"Circulation."},{"key":"819_CR19","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1097\/CCM.0b013e3181eed90a","volume":"38","author":"S Wang","year":"2010","unstructured":"Wang S, Li CS, Ji XF. Effect of continuous compressions and 30:2 cardiopulmonary resuscitation on global ventilation\/perfusion values during resuscitation in a porcine model. Crit Care Med. 2010;38:2024\u201330.","journal-title":"Crit Care Med"},{"issue":"12","key":"819_CR20","doi-asserted-by":"publisher","first-page":"e82677","DOI":"10.1371\/journal.pone.0082677","volume":"8","author":"Q Zhang","year":"2013","unstructured":"Zhang Q, Li C. Combination of epinephrine with esmolol attenuates post-resuscitation myocardial dysfunction in a porcine model of cardiac arrest. PLoS One. 2013;8(12):e82677.","journal-title":"PLoS One"},{"issue":"4","key":"819_CR21","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1111\/j.1582-4934.2009.00744.x","volume":"13","author":"PK Mishra","year":"2009","unstructured":"Mishra PK, Tyagi N, Kumar M. MicroRNAs as therapeutic target for cardiovascular diseases. J Cell Mol Med. 2009;13(4):778\u201389.","journal-title":"J Cell Mol Med"},{"key":"819_CR22","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.resuscitation.2018.01.019","volume":"124","author":"KC Cha","year":"2018","unstructured":"Cha KC, Kim HI, Kim OH, Cha YS, Kim H, Lee KH, Hwang SO. Echocardiographic patterns of\u2002postresuscitation\u2002myocardial\u2002dysfunction. Resuscitation. 2018;124:90\u20135.","journal-title":"Resuscitation."},{"issue":"12","key":"819_CR23","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1016\/j.ajem.2013.08.017","volume":"31","author":"CJ Wu","year":"2013","unstructured":"Wu CJ, Li CS, Zhang Y, Yang J, Yin Q, Hang CC. Differences of\u2002postresuscitation\u2002myocardial\u2002dysfunction\u2002in ventricular fibrillation versus asphyxiation. Am J Emerg Med. 2013;31(12):1690\u20136.","journal-title":"Am J Emerg Med"},{"issue":"3","key":"819_CR24","doi-asserted-by":"publisher","first-page":"H1069","DOI":"10.1152\/ajpheart.00694.2010","volume":"300","author":"M Cai","year":"2011","unstructured":"Cai M, Li Y, Xu Y, Swartz HM, Chen CL, Chen YR, He G. Endothelial\u2002NOS\u2002activity and\u2002myocardial\u2002oxygen metabolism define the salvageable ischemic time window for ischemic postconditioning. Am J Physiol Heart Circ Physiol. 2011;300(3):H1069\u201377.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"819_CR25","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s00395-015-0490-9","volume":"110","author":"SU Eisenhardt","year":"2015","unstructured":"Eisenhardt SU, Weiss JB, Smolka C, Maxeiner J, Pankratz F, Bemtgen X, Kustermann M, Thiele JR, Schmidt Y, Bjoern Stark G, Moser M, Bode C, Grundmann S. MicroRNA-155\u2002aggravates\u2002ischemia-reperfusion\u2002injury\u2002by modulation of inflammatory cell recruitment and the respiratory oxidative burst. Basic Res Cardiol. 2015;110(3):32.","journal-title":"Basic Res Cardiol"},{"key":"819_CR26","first-page":"8948657","volume":"2019","author":"Z Liu","year":"2019","unstructured":"Liu Z, Tao B, Fan S, Pu Y, Xia H, Xu L. MicroRNA-145\u2002protects against\u2002myocardial\u2002ischemia\u2002reperfusion\u2002injury\u2002via CaMKII-mediated Antiapoptotic and anti-inflammatory pathways. Oxidative Med Cell Longev. 2019;2019:8948657.","journal-title":"Oxidative Med Cell Longev"},{"key":"819_CR27","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.freeradbiomed.2017.01.010","volume":"104","author":"J Kim","year":"2017","unstructured":"Kim J, Lee KS, Kim JH, Lee DK, Park M, Choi S, Park W, Kim S, Choi YK, Hwang JY, Choe J, Won MH, Jeoung D, Lee H, Ryoo S, Ha KS, Kwon YG, Kim YM. Aspirin prevents TNF-\u03b1-induced\u2002endothelial\u2002cell dysfunction by regulating the NF-\u03baB-dependent\u2002miR-155\/eNOS pathway: role of a\u2002miR-155\/eNOS axis in preeclampsia. Free Radic Biol Med. 2017;104:185\u201398.","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"819_CR28","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1517\/14728222.2013.745512","volume":"17","author":"D Santovito","year":"2013","unstructured":"Santovito D, Mandolini C, Marcantonio P, De Nardis V, Bucci M, Paganelli C, Magnacca F, Ucchino S, Mastroiacovo D, Desideri G, Mezzetti A, Cipollone F. Overexpression of microRNA-145 in atherosclerotic plaques from hypertensive patients. Expert Opin Ther Targets. 2013;17(3):217\u201323.","journal-title":"Expert Opin Ther Targets"},{"issue":"1","key":"819_CR29","first-page":"548","volume":"15","author":"Y Wang","year":"2018","unstructured":"Wang Y, Jin L. miRNA-145 is associated with spontaneous hypertension by targeting SLC7A1. Exp Ther Med. 2018;15(1):548\u201352.","journal-title":"Exp Ther Med"},{"key":"819_CR30","doi-asserted-by":"publisher","first-page":"H1603","DOI":"10.1152\/ajpheart.00963.2003","volume":"286","author":"ML Riess","year":"2004","unstructured":"Riess ML, Stowe DF, Warltier DC. Cardiac pharmacological preconditioning with volatile anesthetics: from bench to bedside. Am J Physiol Heart Circ Physiol. 2004;286:H1603\u20137.","journal-title":"Am J Physiol Heart Circ Physiol"}],"container-title":["Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13049-020-00819-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13049-020-00819-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13049-020-00819-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T15:11:30Z","timestamp":1610205090000},"score":1,"resource":{"primary":{"URL":"https:\/\/sjtrem.biomedcentral.com\/articles\/10.1186\/s13049-020-00819-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,6]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["819"],"URL":"https:\/\/doi.org\/10.1186\/s13049-020-00819-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-89490\/v1","asserted-by":"object"}]},"ISSN":["1757-7241"],"issn-type":[{"value":"1757-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,6]]},"assertion":[{"value":"3 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2"}}